Akido Labs Secures $60M Series B to Revolutionize Accessible, Empathetic Healthcare

We are thrilled to announce that Akido Labs has successfully raised $60,000,000 in funding, a milestone that reinforces our commitment to reimagining the future of healthcare. Since our founding in 2015 by leaders in technology, social enterprise, and hospital administration, our mission has remained resolute—to bridge technology and empathy, making exceptional healthcare a basic human right. This significant investment will empower us to accelerate the development and deployment of our next-generation healthcare platform, which harnesses the power of artificial intelligence, advanced medicine, and innovative engineering to anticipate patient needs and deliver precision care. The funding not only validates our vision but also enables us to expand our groundbreaking efforts across both urban and remote regions, ensuring that high-quality healthcare is accessible to everyone regardless of financial means or geography. By integrating state-of-the-art technology with deep human insight, we are building a system that is both responsive and inclusive—one that is poised to transform patient experiences by offering tailored, real-time solutions that were once unimaginable. Looking ahead, the new capital will be strategically funneled into further enhancing our AI-driven diagnostic tools, broadening our research and development initiatives, and scaling our operations to meet growing demand. We remain dedicated to partnering with communities, healthcare professionals, and innovators across the globe to create a world where healthcare evolves in tandem with technology. At Akido Labs, this funding is more than a financial boost—it’s a decisive step toward revolutionizing care, one that underscores our unwavering promise to support the wellbeing of every individual we serve.